Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Life360 (LIF) Research & Development (2021 - 2025)

Life360 (LIF) has disclosed Research & Development for 5 consecutive years, with $33.3 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 11.92% to $33.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $128.4 million through Dec 2025, up 13.56% year-over-year, with the annual reading at $128.4 million for FY2025, 13.56% up from the prior year.
  • Research & Development for Q4 2025 was $33.3 million at Life360, up from $32.4 million in the prior quarter.
  • The five-year high for Research & Development was $33.3 million in Q4 2025, with the low at $12.0 million in Q2 2021.
  • Average Research & Development over 5 years is $25.5 million, with a median of $27.0 million recorded in 2024.
  • The sharpest move saw Research & Development surged 124.96% in 2022, then decreased 14.24% in 2023.
  • Over 5 years, Research & Development stood at $15.2 million in 2021, then soared by 65.71% to $25.1 million in 2022, then increased by 3.48% to $26.0 million in 2023, then rose by 14.49% to $29.8 million in 2024, then increased by 11.92% to $33.3 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $33.3 million, $32.4 million, and $32.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.